Heart. 2020;106(15):1160-1168.
Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
제1저자 손미경, 박진주 · 교신저자 김원호, 최동주
소속 (4)
- Division of Cardiovascular Diseases, Korea National Institute of Health, Cheongju, Chungcheongbuk-do, The Republic of Korea.
- Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, The Republic of Korea.
- Division of Cardiovascular Diseases, Korea National Institute of Health, Cheongju, Chungcheongbuk-do, The Republic of Korea jhkwh@nih.go.kr djchoi@snubh.org.
- Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, The Republic of Korea jhkwh@nih.go.kr djchoi@snubh.org.
Abstract
OBJECTIVE To determine the prognostic value of atrial fibrillation (AF) in patients with heart failure (HF) and preserved, mid-range or reduced ejection fraction (EF).
METHODS Patients hospitalised for acute HF were enrolled in the Korean Acute Heart Failure registry, a prospective, observational, multicentre cohort study, between March 2011 and February 2014. HF types were defined as reduced EF (HFrEF, LVEF <40%), mid-range EF (HFmrEF, LVEF 40%-49%) or preserved EF (HFpEF, LVEF ≥50%).
RESULTS Of 5414 patients enrolled, HFrEF, HFmrEF and HFpEF were seen in 3182 (58.8%), 875 (16.2%) and 1357 (25.1%) patients, respectively. The prevalence of AF significantly increased with increasing EF (HFrEF 28.9%, HFmrEF 39.8%, HFpEF 45.2%; p for trend <0.001). During follow-up (median, 4.03 years; IQR, 1.39-5.58 years), 2806 (51.8%) patients died. The adjusted HR of AF for all-cause death was 1.06 (0.93-1.21) in the HFrEF, 1.10 (0.87-1.39) in the HFmrEF and 1.22 (1.02-1.46) in the HFpEF groups. The HR for the composite of all-cause death or readmission was 0.97 (0.87-1.07), 1.14 (0.93-1.38) and 1.03 (0.88-1.19) in the HFrEF, HFmrEF and HFpEF groups, respectively, and the HR for stroke was 1.53 (1.03-2.29), 1.04 (0.57-1.91) and 1.90 (1.13-3.20), respectively. Similar results were observed after propensity score matching analysis.
CONCLUSIONS AF was more common with increasing EF. AF was seen to be associated with increased mortality only in patients with HFpEF and was associated with an increased risk of stroke in patients with HFrEF or HFpEF.
TRIAL REGISTRATION NUMBER NCT01389843.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Keywords
atrial fibrillationepidemiologyheart failure with preserved ejection fractionheart failure with reduced ejection fractionstroke
Figures
그림 출처: PubMed Central 공개 논문 (PMC7398483)
Comment · 정정
Conflict of interest statement
Competing interests: None declared.
그 밖의 정보
- 출판 형태
- Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't
- 저널
- Heart (British Cardiac Society) · eISSN 1468-201X
- 전자 출판
- 2020-04-27
- MeSH
- Aged · Aged, 80 and over · Atrial Fibrillation / diagnosis / mortality / physiopathology / therapy · Cause of Death · Female · Heart Failure / diagnosis / mortality / physiopathology / therapy · Heart Rate* · Humans · Male · Middle Aged · Patient Readmission · Prevalence · Prognosis · Prospective Studies · Registries · Republic of Korea / epidemiology · Risk Assessment · Risk Factors · Stroke / diagnosis / mortality / physiopathology / therapy · Stroke Volume* · Time Factors · Ventricular Function, Left*
- 데이터
- ClinicalTrials.gov: NCT01389843
- 참고문헌
- 29편